Tel：+86-18874232226 WhatsApp：+86-18874232226 E-mail：lisa@qankorey.com
Qankorey's One Step Dementia Risk Test Kit Showcased at the 8th National Congress
Visits:
2025-08-19
Vung Tau, Vietnam – 2025 National Neurology Scientific Conference, a highly influential event in Vietnam's neuromedicine field, was grandly held from August 15-17 at the Pullman Vung Tau Hotel. Organized by the Vietnam Neurological Association (VNA), the summit attracted over 800 distinguished attendees including senior professors, clinicians, healthcare administrators, and hospital directors, solidifying its position as Vietnam's premier neuromedicine platform.
As Vietnam's leading non-governmental professional organization in neurology, VNA remains committed to advancing academic exchange and industry development. The congress not only provided a high-level platform for medical professionals to share cutting-edge research and discuss clinical challenges, but also offered medical enterprises, pharmaceutical companies, and health nutrition providers valuable opportunities for product demonstration and brand promotion.
At this prestigious gathering, Qankorey emerged as a standout innovator with its groundbreaking One Step Dementia Risk Test Kit for early Alzheimer's disease (AD) screening.
AD, a progressive neurodegenerative disorder, requires early detection for effective intervention. Qankorey's revolutionary non-invasive urine test overcomes traditional screening limitations, enabling accurate risk assessment without complex invasive procedures. This technological leap significantly enhances screening accessibility, marking a paradigm shift in clinical diagnosis and patient management.
The company's exhibition booth became the congress' focal point, drawing crowds of experts, clinicians, and industry leaders who engaged in in-depth discussions about the product's technical principles, performance advantages, and clinical applications. Attendees unanimously praised the innovation, recognizing its potential to transform early AD prevention and redefine industry screening standards.
Notably, the product has obtained medical product registration certification from Vietnam's Ministry of Health (MOH), accelerating its market deployment. This milestone not only demonstrates official endorsement but also represents a strategic advance in Qankorey's Southeast Asian expansion.
"This participation holds profound significance for our global strategy," said a Qankorey representative. "Through dialogues with international experts, we're refining our technology while expanding our Southeast Asian footprint – contributing Chinese innovation to global AD prevention."
Looking ahead, as Qankorey continues to deepen its presence in the Southeast Asian market, this product is bound to benefit more patients and inject new vitality into the development of the global neuroscience field.
Previous: No more!
Next: Qankorey’s Invitation | We’re Exhibiting at AAIC 2025!
RELATED INFORMATION
Domestic business consulting Tel:+86-731-85714218
E-mail:qankorey@qankorey.com
Internation Marketing Tel:+86-18874232226
E-mail:lisa@qankorey.com
Company address: 12F, Building 15, No.188 Middle Huanbao Road, Yuhua District, Changsha, Hunan, 410116, China
Production Address: 4F, Building 7, Yuhua Intelligent Manufacturing Center, No.2 Hongda Road, Tongsheng Street, Yuhua District, Changsha City, Hunan Province, China 410007
Public Number
Small program
Jingdong
Taobao